Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Treatment Clinical Trials for Soft Tissue Sarcoma

Review the soft tissue sarcoma treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 51-75 of 118

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
Status: Active
Location: 2 locations
Autologous B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) for the Treatment of Children and Young Adults with Relapse or Refractory Neuroblastoma, Soft Tissue Sarcoma, Osteosarcoma, Ewing Sarcoma, and Wilms Tumor
Status: Active
Location: 2 locations
In Situ Immunomodulation for Unresectable and Metastatic Solid Tumors
Status: Active
Location: 2 locations
AOH1996 for the Treatment of Refractory Solid Tumors
Status: Active
Location: 2 locations
Focused Ultrasound for the Promotion of Immune Responses for Newly Diagnosed or Metastatic Undifferentiated Pleomorphic Sarcoma
Status: Active
Location: 2 locations
Hypofractionated Radiation Therapy before Surgery for the Treatment of Resectable Retroperitoneal Soft Tissue Sarcoma
Status: Active
Location: 2 locations
Hypofractionated Radiation for Preoperative Treatment of Patients with Sarcoma
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Investigating a Shortened Course of Radiation Therapy for Soft Tissue Sarcomas Arising in the Abdomen and/or Pelvis, MARS Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Hypofractionated Radiotherapy followed by Surgery for the Treatment of Soft Tissue Sarcomas
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Pencil Beam Scanning Proton Beam Radiation Therapy in Treating Patients with Kidney Tumors
Status: Active
Location: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Nab-Paclitaxel and Gemcitabine Hydrochloride in Treating Teenagers or Young Adults with Recurrent or Refractory Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma, or Soft Tissue Sarcoma
Status: Active
Location: 4 locations
5-Day Hypofractionated Radiotherapy before Surgery for the Treatment of Soft Tissue Sarcoma of the Arms, Legs, or Trunk
Status: Active
Location: Medical University of South Carolina, Charleston, South Carolina
External Beam Radiation Therapy for Preoperative Treatment of Patients with Soft Tissue Sarcoma
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
MRI Habitat-Directed Radiation for the Treatment of High-Grade Soft Tissue Sarcoma
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Propranolol for the Treatment of Adult Patients with Kaposi Sarcoma
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Sunitinib and Regorafenib for the Treatment of Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors and KIT Gene Mutations
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Paclitaxel and Radiation Therapy in Treating Patients with Cutaneous Angiosarcoma
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Pembrolizumab for the Treatment of Metastatic or Advanced Cutaneous Soft Tissue Sarcomas
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Doxorubicin for the Treatment of Elderly Patients with Advanced or Metastatic Soft Tissue Leiomyosarcoma
Status: Active
Location: UCHealth University of Colorado Hospital, Aurora, Colorado
Regorafenib for the Treatment of Specific Gastrointestinal Stromal Tumors Mutation Subsets
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Cytoreductive Surgery with Gemcitabine Followed by Dacarbazine for the Treatment of Locally Recurrent Uterine Leiomyosarcoma
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Ubamatamab Alone or in Combination with Cemiplimab for Patients with Locally Advanced or Metastatic Renal Medullary Carcinoma or Epithelioid Sarcoma that is MUC16-Expressing SMARCB1-Deficient
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
Status: Active
Location: Northwestern University, Chicago, Illinois